HHS takes action against Gilead; a report on fears of seasonal workers in Montana; the latest CDC data on preventable deaths show differences between urban and rural areas.
After failing to reach a licensing deal with Gilead, HHS sued the drug maker in federal court, saying the company is infringing on patents held by CDC and paid for by taxpayers. AIDS activists maintain that the government could use the royalties to fund HIV prevention and treatment services. Gilead said in a statement the patents are not valid, STAT News reported.
Seasonal workers in Montana who had been eligible for health coverage under Medicaid expansion worry they may lose access to benefits due to new reporting requirements that could go into effect in January, according to Kaiser Health News. However, similar work requirement laws were blocked this year in Arkansas, Kentucky, and New Hampshire.
In 2017, the 5 leading causes of death for persons older than 80 years in the United States were heart disease, cancer, unintentional injury, chronic lower respiratory disease, and stroke, according to data released Thursday in the CDC's Morbidity and Mortality Weekly Report. For the study period, percentages were higher for all 5 in nonmetropolitan counties.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Elevating Equitable Health Care for the LGBTQ+ Community
June 18th 2024For the third episode in our special Pride Month series, we speak with Patrick McGovern, CEO of Callen-Lorde since August of 2023 and an outspoken advocate for HIV; lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+); and community health.
Listen
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More